ARCT Earnings Preview: Options Price a ±44.9% Move
· The NYC Memo · ARCT reports 2026-11-09
Arcturus Therapeutics Holdings reports November 9, 2026. The June 17, 2027 straddle implies ±44.87% against a 9.70% average reaction, with dealers long gamma and max pain at $11.
Live updates
Nov 6 — implied move ±32.20% to ±44.87%; ATM implied vol 89.2% to 95.7%; spot $10.87 to $9.36; put/call open interest 3.05 to 2.48. The straddle now prices ±44.87% with ARCT at $9.36 and dealers long gamma.
Arcturus Therapeutics Holdings reports on November 9, 2026. The June 17, 2027 straddle is priced at $4.20, an implied move of ±44.87% against an average realised reaction of 9.70% over the last 8 prints. The stock trades at $9.36, -47.9% from its 52-week high, with dealers long gamma and max pain at $11.
What the options market is pricing
| Measure | Level |
|---|---|
| November 9, 2026 | |
| Expiry used | June 17, 2027 (223 days out) |
| Spot | $9.36 |
| ATM straddle | $4.20 |
| Implied move | ±44.87% ($5.16 to $13.56) |
| ATM implied vol | 95.7% |
| Put/call open interest | 2.48 |
| Max pain | $11 |
| Net dealer gamma | +$0.00mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $10 (13 contracts) |
| Heaviest put strike below spot | $7 (2 contracts) |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ARCT between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 6 | +21.87% |
| Q1 2026, May 7 | +3.60% |
| Q4 2025, Mar 3 | -4.17% |
| Q3 2025, Nov 10 | -1.25% |
| Q2 2025, Aug 11 | +30.73% |
| Q1 2025, May 12 | +2.33% |
| Q4 2024, Mar 6 | -8.89% |
| Q3 2024, Nov 7 | +4.75% |
Across the last 8 prints the average absolute reaction is 9.70%, with 5 higher and 3 lower. The best was +30.73% and the worst -8.89%. Options are asking ±44.87%, which is 35.17 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $9.36 |
| 52-week range | $5.50 to $17.96 |
| Position in that range | 31% |
| From the 52-week high | -47.9% |
| From the 52-week low | +70.2% |
| Past week | -23.0% |
| Past month | -26.7% |
| Past three months | +26.3% |
| 50-day average | $13.22 |
| 200-day average | $9.05 |
How the options market is pricing it
The June 17, 2027 straddle marks $5.16 to $13.56 as the range the options market is paying for into the print, with ATM implied vol at 96% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ARCT has moved 9.70% on earnings against the ±44.87% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ARCT before the print.
Data as of November 6, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ARCT options memo